IDEXX Laboratories Inc (BSP:I1DX34)
R$ 545.37 0 (0%) Market Cap: 224.44 Bil Enterprise Value: 228.24 Bil PE Ratio: 44.50 PB Ratio: 23.46 GF Score: 99/100

IDEXX Laboratories Inc Investor Day ( a discussion with an IDEXX customer and veterinary) Transcript

Aug 15, 2019 / 12:00PM GMT
Jay Mazelsky
IDEXX Laboratories, Inc. - Interim President & CEO

Good morning, everybody. This is IDEXX Laboratories 2019 Investor Day, day 2, and welcome to those listening on the webcast.

I'd like to quickly run through the agenda we planned for you this morning, which will go to 12:00 noon. We'll first cover our diagnostics businesses with Dr. Tina Hunt, who will strategically review our VetLaB and Rapid Assay business; followed by Mike Lane, who's our global leader in reference labs. We plan to take a break for approximately 20 minutes and then turn over -- and then turn to our commercial businesses with Jim Polewaczyk, and Kathy Turner will review detailed overviews of our commercial regions and plans.

And then following a short break, George Fennell, our Corporate Vice President of North American sales, will facilitate a 40-minute discussion with an IDEXX customer and one of our veterinary diagnostic consultants, spotlighting preventive care. Brian, I and the broader management team will then have the opportunity to take your questions for the remainder of the allotted time.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot